Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,249,284
  • Shares Outstanding, K 304,781
  • Annual Sales, $ 1,190 K
  • Annual Income, $ -444,040 K
  • EBIT $ -430 M
  • EBITDA $ -400 M
  • 60-Month Beta 0.55
  • Price/Sales 1,891.74
  • Price/Cash Flow N/A
  • Price/Book 2.67

Options Overview Details

View History
  • Implied Volatility 185.24% ( +60.21%)
  • Historical Volatility 62.65%
  • IV Percentile 91%
  • IV Rank 52.22%
  • IV High 320.56% on 08/07/24
  • IV Low 37.36% on 08/15/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 3,157
  • Volume Avg (30-Day) 6,194
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 211,825
  • Open Int (30-Day) 243,947

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.26
  • Number of Estimates 7
  • High Estimate -0.20
  • Low Estimate -0.30
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +42.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.06 +6.16%
on 12/18/24
9.70 -22.73%
on 11/25/24
-1.06 (-12.34%)
since 11/22/24
3-Month
7.06 +6.16%
on 12/18/24
12.51 -40.06%
on 11/07/24
-2.16 (-22.41%)
since 09/23/24
52-Week
6.70 +11.87%
on 12/27/23
18.33 -59.11%
on 02/28/24
-0.85 (-10.13%)
since 12/22/23

Most Recent Stories

More News
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

IOVA : 7.39 (+0.14%)
If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These

These windows of opportunity aren't likely to remain open for much longer.

IOVA : 7.39 (+0.14%)
KO : 61.82 (-1.17%)
LYFT : 13.59 (+0.15%)
UBER : 61.64 (+1.50%)
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there are a pair of biopharma stocks that Wall Street expects to rocket higher in 2025....

CRSP : 40.21 (-1.25%)
IOVA : 7.39 (+0.14%)
VRTX : 398.11 (+0.21%)
Prediction: This Stock Will Beat the Market in 2025

It hasn't been a great year for Iovance Biotherapeutics (NASDAQ: IOVA), an innovative mid-cap biotech company. The drugmaker's shares have significantly lagged the market -- advancing only about 5% so...

IOVA : 7.39 (+0.14%)
3 Monster Stocks to Hold for the Next 10 Years

Just be ready to ride out some inevitable turbulence along the way.

IOVA : 7.39 (+0.14%)
WOLF : 7.35 (+4.40%)
PANW : 188.30 (+0.81%)
Is Iovance Biotherapeutics Stock a Millionaire Maker?

The biotech industry has been described as the Wild West of the stock market. Although some companies manage to develop and commercialize a life-changing therapeutic, countless more start-ups inevitably...

IOVA : 7.39 (+0.14%)
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

IOVA : 7.39 (+0.14%)
Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back

As the rising star of cell therapy biotechs, Iovance Biotherapeutics (NASDAQ: IOVA) is a hot stock that's capturing a lot of attention, and for good reason. Iovance's one-of-a-kind medicine is already...

IOVA : 7.39 (+0.14%)
2 Innovative Stocks That Could Deliver Outsize Returns

Many of Wall Street's largest and most successful stocks became so thanks to innovation. It's too late to get in on the ground floor with those that are already well-established leaders in their fields,...

IOVA : 7.39 (+0.14%)
RXRX : 6.47 (+7.30%)
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

Biotechs often need several years to realize their visions, even after they have a drug approved for the first time. There's typically plenty of upside in store for enterprising and patient investors.

CRSP : 40.21 (-1.25%)
IOVA : 7.39 (+0.14%)
VRTX : 398.11 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own...

See More

Key Turning Points

3rd Resistance Point 7.89
2nd Resistance Point 7.67
1st Resistance Point 7.52
Last Price 7.39
1st Support Level 7.15
2nd Support Level 6.93
3rd Support Level 6.78

See More

52-Week High 18.33
Fibonacci 61.8% 13.89
Fibonacci 50% 12.51
Fibonacci 38.2% 11.14
Last Price 7.39
52-Week Low 6.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar